JBJS Reviews is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the fields of Orthopedics, Sports Medicine, and Surgery. With an impactful presence in the medical community, the journal is recognized for its high-quality and peer-reviewed content that boasts an impressive ranking, including a Q1 quartile status in both Orthopedics and Surgery as of 2023. This esteemed publication is indexed in Scopus, achieving a rank of #115 out of 551 in Medicine Surgery and #88 out of 321 in Medicine Orthopedics and Sports Medicine. Since its inception in 2014, JBJS Reviews has served as a critical platform for advancing knowledge and fostering innovation, offering researchers, professionals, and students valuable insights into the latest advancements, evidence-based practices, and trends in the orthopedic field. Although not currently offering open access, JBJS Reviews remains a pivotal resource for those aiming to stay at the forefront of orthopedic and surgical excellence.

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

Precision Clinical Medicine, published by Oxford University Press, is an esteemed open-access journal that has been at the forefront of clinical research since its inception in 2018. With an ISSN of 2096-5303, this journal specializes in the rapidly evolving field of precision medicine, which aims to tailor healthcare to individual patient characteristics, needs, and preferences. As a testament to its influence, Precision Clinical Medicine holds a remarkable rank of #34 out of 636 in the General Medicine category on Scopus, placing it within the 94th percentile of its field and earning a prestigious Q1 rating in 2023. Based in the United Kingdom, the journal not only provides open access content, ensuring that groundbreaking research is widely disseminated, but also serves as a crucial platform for innovations and discussions that shape modern medical practices. Researchers, professionals, and students alike will find valuable insights and influential studies that drive the future of personalized healthcare within its pages.

BRITISH JOURNAL OF HOSPITAL MEDICINE is a distinguished publication in the field of medicine, focusing primarily on the latest research, clinical practices, and advancements in hospital medicine. Published by MA HEALTHCARE LTD in the United Kingdom, this journal serves as a critical resource for healthcare professionals, researchers, and students alike, featuring insightful articles that bridge the gap between theory and practice. Holding a Q3 ranking in the miscellaneous medicine category and positioned within the top half of Scopus rankings, the journal underscores its commitment to high-quality, peer-reviewed content. With its inception dating back to 1996, the BRITISH JOURNAL OF HOSPITAL MEDICINE has evolved to include a broad spectrum of topics relevant to contemporary hospital settings, ensuring its readers are well-equipped with the knowledge necessary for improving patient care. Access options are tailored to modern readership, enhancing the visibility and dissemination of vital medical research.

Clinical and Investigative Medicine is a prestigious journal dedicated to advancing the fields of clinical research and medical practice, published by the Canadian Society for Clinical Investigation. With a history of insightful contributions since its inception in 1978, the journal serves as a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and explore critical issues facing contemporary medicine. Housed within the Q3 quartile of the Medicine category, it boasts an impressive Scopus ranking of #280/636, placing it within the 56th percentile amongst its peers. Although it operates on a subscription basis, the journal remains accessible to a broad audience interested in comprehensive reviews, original research, and cutting-edge methodology, ensuring that vital information reaches a global readership. Submit your research to Clinical and Investigative Medicine and contribute to the ongoing dialogue that shapes the future of patient care and medical innovation.

The JOURNAL OF INTERNAL MEDICINE, a prestigious publication in the field of Internal Medicine, is published by WILEY and ranks among the top journals in its category, holding a remarkable Q1 designation in the 2023 Scopus Rankings. With its ISSN 0954-6820 and E-ISSN 1365-2796, this journal has garnered a significant impact within the medical community, being ranked 7th out of 167 in the field and maintaining a remarkable 96th percentile ranking. The journal covers a broad spectrum of research topics relevant to internal medicine, providing vital insights that advance clinical practices and enhance patient care. Since its inception in 1989, the JOURNAL OF INTERNAL MEDICINE has established itself as an essential resource for researchers, healthcare professionals, and students, facilitating the dissemination of groundbreaking studies and fostering academic discourse. Despite its traditional access model, the journal's commitment to high-quality research remains unwavering, making it a cornerstone in the field of Internal Medicine.

Nature Reviews Clinical Oncology is a premier journal dedicated to the comprehensive exploration and critical evaluation of current advancements in the field of clinical oncology. Published by the esteemed NATURE PORTFOLIO in the United Kingdom, this influential journal boasts an impressive impact factor that reflects its significant role in shaping oncology research. As a Q1 ranked journal in Scopus, it occupies a notable position within the top tier of oncology publications, placing it in the 99th percentile among its peers. With a history of convergence from 2009 to 2024, it presents high-quality content through an open-access model, ensuring accessibility to vital research findings. Researchers, professionals, and students alike will find Nature Reviews Clinical Oncology an invaluable resource for staying abreast of the latest trends, biologic insights, and therapeutic innovations that drive the future of cancer treatment.

Journal of Clinical Oncology is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the field of oncology and cancer research. Since its inception in 1983, this influential journal has consistently ranked in the Q1 category across multiple disciplines, including cancer research, medicine, and oncology, reflecting its critical role in shaping the future of cancer therapeutics and patient care. With a Scopus ranking of #9 in Medicine - Oncology and #6 in Biochemistry, Genetics and Molecular Biology - Cancer Research, Journal of Clinical Oncology publishes cutting-edge original research, reviews, and clinical updates that are essential for professionals, researchers, and students alike. Although it does not currently offer open access options, it provides invaluable insights and evidence-based findings that are crucial for advancing oncological knowledge and improving patient outcomes globally. The journal’s continued commitment to excellence ensures its place as a vital resource in the oncological community.

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

ONCOLOGIST is a premier, open-access journal published by Oxford University Press, advancing the field of cancer research since its inception in 1996. With an impressive H-Index and a prestigious placement within the Q1 category in Cancer Research, Medicine, and Oncology for 2023, ONCOLOGIST stands at the forefront of oncological science, boasting a Scopus rank of #55 out of 404 in Medicine and #47 out of 230 in Cancer Research. This journal not only disseminates cutting-edge research but also aims to foster multidisciplinary approaches that are critical for addressing the complex challenges faced in cancer therapy and survivorship. Be part of a vibrant community as you explore impactful research articles that contribute to the global conversation on cancer. ONCOLOGIST is dedicated to providing an accessible platform for authors and readers alike, ensuring that high-quality research is available to all stakeholders in the fight against cancer.